PPARG Could Work as a Valid Therapeutic Strategy for the Treatment of Lung Squamous Cell Carcinoma

Previous studies showed that PPAR-gamma (PPARG) ligands might serve as potential therapeutic agents for nonsmall cell lung cancer (NSCLC). However, a few studies reported the specific relationship between PPARG and lung squamous cell carcinoma (LSCC). Here, we made an effort to explore the relations...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Shunbin, Yu, Guiping, Huang, Bin, Mi, Yedong, Kang, Yan, Simon, Julia Pia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285416/
https://www.ncbi.nlm.nih.gov/pubmed/32565768
http://dx.doi.org/10.1155/2020/2510951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285416/
https://www.ncbi.nlm.nih.gov/pubmed/32565768
http://dx.doi.org/10.1155/2020/2510951

Ejemplares similares